Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Chronic Sialorrhea Market’s Growth Trajectory From 2025 To 2034?
In recent times, the chronic sialorrhea market has seen significant expansion. This market is projected to escalate from $0.72 billion in 2024 to $0.76 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the historic phase is a result of the rise in neurological disorders, population growth, increased recognition and diagnosis of these disorders, and a boost in demand for non-invasive treatments.
Expectations are high for robust growth in the chronic sialorrhea market in the upcoming years. It is predicted to expand to $0.97 billion by 2029, with a compound annual growth rate (CAGR) of 6.1%. The anticipated growth during the forecast period is motivated by factors such as a heightened awareness of treatment choices, urgent need for effective treatments, escalated healthcare spending, increasing instances in children, and a growing demand for oral gels and fluids. Major tendencies for the forecast period encompass telemedicine for distant monitoring, patient-focused care models, pharmacological breakthroughs, the integration of speech and occupational therapies, and the invention of long-lasting pharmaceuticals.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21149&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Chronic Sialorrhea Market?
The chronic sialorrhea market is anticipated to expand due to the growing occurrence of neurodegenerative disorders. These disorders include diseases that lead to the progressive deterioration or death of nerve cells in the brain and spinal cord. The escalation in these disorders can be attributed to genetic and environmental factors, a greater comprehension of disease processes, chronic health issues, and social and psychological factors. Chronic sialorrhea is a frequent complication of neurodegenerative disorders like Parkinson’s disease and ALS, requiring specific treatments to avoid aspiration, improve oral function and enhance patient comfort. For example, Parkinson’s UK, a UK-based charity, reported that in September 2023, approximately 153,000 UK citizens are living with Parkinson’s. This figure, due to an aging population, is expected to see a 20% increase, reaching a predicted 172,000 by 2030. Consequently, the increasing occurrence of neurodegenerative disorders will fuel the growth of the chronic sialorrhea market.
Which Key Market Segments Comprise the Chronic Sialorrhea Market and Drive Its Revenue Growth?
The chronic sialorrheamarket covered in this report is segmented –
1) By Treatment Type: Pharmacological Treatments; Botulinum Toxin Injections; Surgical Interventions; Medical Devices And Assistive Therapies
2) By Route Of Administration: Oral Medications; Injectable Treatments; Topical Applications
3) By Patient Population: Pediatric Patients; Adult Patients
4) By End-User: Hospitals And Specialty Clinics; Rehabilitation Centers; Homecare Settings
Subsegments:
1) By Pharmacological Treatments: Anticholinergic Medications; Antidepressants; Alpha-adrenergic Agonists; Salivary Gland Modulators
2) By Botulinum Toxin Injections: Botulinum Toxin Type A (Botox); Botulinum Toxin Type B (Myobloc); Localized Salivary Gland Injections
3) By Surgical Interventions: Sialendoscopy; Salivary Gland Duct Dilation or Stenting; Parotid Duct Surgery; Submandibular Gland Removal (Sialadenectomy)
4) By Medical Devices And Assistive Therapies: Oral Dryness Devices; Salivary Stimulation Devices; Lip and Mouth Exercises; Artificial Salivary Glands
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21149&type=smp
Which Areas Are Leading Regions in the Chronic Sialorrhea Market Expansion Across the Globe?
North America was the largest region in the chronic sialorrhea market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic sialorrhea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theChronic Sialorrhea Market Direction?
Leading firms in the chronic sialorrhea industry are concentrating on the invention of new treatment methods. These include oral solutions aimed at enhancing patients’ tolerance and providing non-intrusive options for handling chronic sialorrhea in children. It aims to boost safety and efficiency while minimizing harmful effects. An example of this is an orally administered liquid medication, which contains the active substance dissolved in a solution for easy swallowing. Proveca Pharma Ltd., a pharmaceutical firm based in the UK, is a prime example which introduced Sialanar (glycopyrronium bromide) in France in February 2023. The treatment targets severe chronic sialorrhea in children suffering from neurological conditions. The product’s key aspect is its liquid form, made for simple administration and accurate dosage. It’s particularly advantageous for young patients who find it hard to consume solid medicines. Its well-recognized safety and efficacy standards aid in life quality improvement by curtailing excessive saliva production often seen in neurodevelopmental disorders like cerebral palsy.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-sialorrhea-global-market-report
How Is the Chronic Sialorrhea Market Conceptually Defined?
Chronic sialorrhea refers to the persistent excessive production or impaired control of saliva, often associated with neurological conditions such as Parkinson’s disease, cerebral palsy, or ALS. It is managed using pharmacological treatments, botulinum toxin injections, or surgical interventions to improve oral function, reduce complications, and enhance patients’ quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21149
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model